Portola Pharmaceuticals Inc. buy stratec
Start price
26.12.17
/
50%
€44.88
Target price
21.02.18
€63.14
Performance (%)
-7.37%
End price
21.02.18
€41.57
Summary
This prediction ended on 21.02.18 with a price of €41.57. With a performance of -7.37%, the BUY prediction by stratec finished with a loss. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % | 52,00 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % | 95,66 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % | 52,99 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % | 66,53 % |
Comments by stratec for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
stratec stimmt der Buy-Einschätzung von klostergang zu
stratec stimmt am 26.12.2017 der Buy-Einschätzung von klostergang mit dem Kursziel 70$ zu.Überschrift: PORTOLA a potential takeover candidate
(Vom Mitglied beendet)
Stopped prediction by stratec for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.97
25.11.18
25.11.18
€31.57
13.01.20
13.01.20
-26.56%
13.01.20
13.01.20
